1. Home
  2. AEHR vs VNDA Comparison

AEHR vs VNDA Comparison

Compare AEHR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$22.07

Market Cap

716.3M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.91

Market Cap

398.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
VNDA
Founded
1977
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.3M
398.9M
IPO Year
1997
2006

Fundamental Metrics

Financial Performance
Metric
AEHR
VNDA
Price
$22.07
$6.91
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.00
AVG Volume (30 Days)
535.3K
1.3M
Earning Date
01-12-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$56,818,000.00
$212,074,000.00
Revenue This Year
$1.91
$12.01
Revenue Next Year
$36.69
$21.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.12
52 Week Low
$6.27
$3.81
52 Week High
$34.35
$7.20

Technical Indicators

Market Signals
Indicator
AEHR
VNDA
Relative Strength Index (RSI) 45.08 66.27
Support Level $21.34 $6.15
Resistance Level $23.20 $7.20
Average True Range (ATR) 1.55 0.48
MACD -0.14 0.05
Stochastic Oscillator 13.77 84.62

Price Performance

Historical Comparison
AEHR
VNDA

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: